1
/
of
0
FDA Drug Approval, N125085, AVASTIN
FDA Drug Approval, N125085, AVASTIN
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 125085
Company: GENENTECH
Drug Name: AVASTIN
Active Ingredients: BEVACIZUMAB
Strength: 400MG
Dosage Form/Route: VIAL; INTRAVENOUS
Action Date: 02/26/2004
Marketing Status: Prescription
Submission Classification:
Company: GENENTECH
Drug Name: AVASTIN
Active Ingredients: BEVACIZUMAB
Strength: 400MG
Dosage Form/Route: VIAL; INTRAVENOUS
Action Date: 02/26/2004
Marketing Status: Prescription
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details